Keyur P. Vora

Cardiologist & Innovator: PASSION = CMRCTEcho STEMI Trials. “Prescribing the Future by Today’s Research” 🇮🇳🇺🇸

[Keyur P. Vora @KeyurVoraMD]

“MIRON-TROP Clinical Trial in “New England Journal of Medicine - Evidence”

https://t.co/FLkG6cdns2

First Ever: Troponin is no longer just a marker of any MI — Post-PCI Troponin is a precision diagnostic method to identify Hemorrhagic MI.
@rohandkumar1 @IUMedSchool @IURadiology

[Keyur P. Vora @KeyurVoraMD]

It was an excellent clinical conference at the SCMR 29th Annual Scientific Sessions at Rio de Janeiro, Brazil to present our latest trials showcasing the critical role of Cardiovascular MRI in STEMI care. @IURadiology @IUMedSchool @IU_Health @rohandkumar1 @SCMR @BrunoLimaMDPhD

[Keyur P. Vora @KeyurVoraMD]

MIRON-TROP trial at #TCT2025 San Francisco

Our research identifies a key driver of in-hospital mortality post-PCI: hemorrhagic myocardial infarction.

We found that post-procedural troponin kinetics can be used to diagnose this critical stage of MI

Thank you @CRFheart & @TCTMD

[Keyur P. Vora @KeyurVoraMD]

Hemorrhagic MI is why STEMI needs a pre-PCI checkpoint. Treat speed + wisdom: before PCI, hold the cine, watch collaterals, record Rentrop. A small pause that upgrades CCU triage, imaging, and follow-up.

Rentrop in every Cath report of MI.
MIRON-CL Trial
https://t.co/GbPr4ZagbY

[FOX59 News @FOX59]

A simple blood test developed by the IU School of Medicine is helping identify heart attack patients at a high risk for complications. https://t.co/1gSiqlchND

[NEJM Evidence @NEJMEvidence]

Intramyocardial hemorrhage following primary PCI is a major predictor of adverse cardiovascular outcomes but is difficult to diagnose in real time. Vora et al. describe the use of post-PCI troponin kinetics to make the diagnosis. https://t.co/JMaXgmRkvb

[Keyur P. Vora @KeyurVoraMD]

Honored to present #ESCAbstract on the #ESCCongress along with NEJM Evidence - MIRON TROP Trial Publication !!!
https://t.co/upSKjXT3DY
Hemorrhagic MI is an independent Risk Factor for In-hospital Mortality !!!
@escardio @ACCinTouch @rohandkumar1 @inacc @NEJMEvidence

[Keyur P. Vora @KeyurVoraMD]

“Not all MIs are the same”

- First Blood Test Diagnostic of Hemorrhagic MI
- First Clinical Trial of Post-PCI High Sensitvity Troponin Kinetics Study
- First acute biomarker to stratify post-PCI patients in CCU⁦@rohandkumar1⁩ ⁦⁦@inacc⁩ https://t.co/sJVvwueSLS

[NEJM Evidence @NEJMEvidence]

Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers https://t.co/1EtKFS7UiV

An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma https://t.co/zuxJTV7LI8

In-Hospital Mortality in Hemorrhagic Myocardial Infarction https://t.co/JMaXgmQMFD

[IU Radiology and Imaging Sciences @IURadiology]

Scientists @KeyurVoraMD and @rohandkumar1 from Medical Imaging Research Institute @IUMedSchool will present their research in @NEJMEvidence at #ESCCongress2025 on Aug. 31, that shows how troponin can predict in-patient hospital deaths after #HemorrhagicMI https://t.co/SbEpTi1Oqo

[Keyur P. Vora @KeyurVoraMD]

I’ll be attending the amazing Indiana-ACC Annual Meeting 2025 on September 13, 2025 at Marriott Indianapolis North. Let me know if you’re planning to attend so that we can say Hi! 👋
Or register now and join me at the event!
https://t.co/7ZenfoaKY2

[Keyur P. Vora @KeyurVoraMD]

Honored to present at #ACCAsia on:
In-hospital Mortality in Hemorrhagic Myocardial Infarction: Diagnostics to Implications

Thank you @ACCinTouch & @SingCardiacSoc for the opportunity to share this work.
Proud to represent @IURadiology & SCVRI India !!!

[Keyur P. Vora @KeyurVoraMD]

@ecgandrhythmRoe Thanks. I am wondering if this patient has RCA subtotal occlusion with TIMI flow < 3. Can you share CAG findings?

[Keyur P. Vora @KeyurVoraMD]

@ecgandrhythmRoe Ischemic monomorphic VT (Nonclassical slow)

[JACC Journals @JACCJournals]

In this #JACCAdvances state-of-the-art review, Dr. Dharmakumar, et al explore advancements & challenges in #cvAMI management. They review 🔑 insights from the prereperfusion era & summarize observations in reperfusion therapy.

Get the details: https://t.co/7DISvDYrEi #cvMI

[Krannert Cardiovascular Research Center @IUKrannertHeart]

Top U.S. #cardiovascular researchers agree that not all #heartattacks are the same. Identifying extent of #myocardialtissue damage is critical they say in #JACCAdvances. https://t.co/nRuwODJpF4

[Keyur P. Vora @KeyurVoraMD]

"Our State-of-the-Art Review traces the history of Myocardial Infarction. Despite decades of reperfusion advances, intramyocardial hemorrhage remains the missing key in post-MI care." @IUMedSchool @IUHealthFdn
https://t.co/VpiQrWXbfM

[Keyur P. Vora @KeyurVoraMD]

@Interve15538505 @POCUSEcho @echotalk @echocardiac @GKardiyolog Right Atrial Thrombus Secondary to Endothelial Damage Post-HD Catheter Removal with Coexisting Chiari Network Remnant at the IVC-RA Junction.
It would be interesting to know PFO status as chiari mostly co-exists with PFO. Share bubble study if you do. Thanks

[Keyur P. Vora @KeyurVoraMD]

@CMichaelGibson Truly a picture of role models and inspiration!

[Krannert Cardiovascular Research Center @IUKrannertHeart]

#IUKrannertHeart investigator @KeyurVoraMD and collaborators, including @rohandkumar1 @IUMedSchool, shared findings from their MIRON-CL and MIRON-RUPTURE clinical trials at #AHA24 on innovative approaches to treating hemorrhagic MI.